These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 31204558)
1. CircRNA_28313/miR-195a/CSF1 axis modulates osteoclast differentiation to affect OVX-induced bone absorption in mice. Chen X; Ouyang Z; Shen Y; Liu B; Zhang Q; Wan L; Yin Z; Zhu W; Li S; Peng D RNA Biol; 2019 Sep; 16(9):1249-1262. PubMed ID: 31204558 [TBL] [Abstract][Full Text] [Related]
2. Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3. Yu FY; Xie CQ; Sun JT; Peng W; Huang XW Life Sci; 2018 Jun; 202():11-20. PubMed ID: 29577879 [TBL] [Abstract][Full Text] [Related]
3. CircRNA_009934 induces osteoclast bone resorption via silencing miR-5107. Miao F; Yin BH; Zhang X; Xue DD; Ma C Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7580-7588. PubMed ID: 32744684 [TBL] [Abstract][Full Text] [Related]
4. A circRNA-miRNA-mRNA network plays a role in the protective effect of diosgenin on alveolar bone loss in ovariectomized rats. Zhang Z; Yue L; Wang Y; Jiang Y; Xiang L; Cheng Y; Ju D; Chen Y BMC Complement Med Ther; 2020 Jul; 20(1):220. PubMed ID: 32664914 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting. Zhang XH; Geng GL; Su B; Liang CP; Wang F; Bao JC Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706599 [TBL] [Abstract][Full Text] [Related]
6. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo. Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508 [TBL] [Abstract][Full Text] [Related]
7. Pseudogene PTENP1 sponges miR-214 to regulate the expression of PTEN to modulate osteoclast differentiation and attenuate osteoporosis. Wang CG; Wang L; Yang T; Su SL; Hu YH; Zhong D Cytotherapy; 2020 Aug; 22(8):412-423. PubMed ID: 32561161 [TBL] [Abstract][Full Text] [Related]
8. Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPARγ and APC. Guo L; Chen K; Yuan J; Huang P; Xu X; Li C; Qian N; Qi J; Shao Z; Deng L; He C; Xu J J Cell Physiol; 2018 Jan; 234(1):581-594. PubMed ID: 30272823 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12. Lian WS; Ko JY; Chen YS; Ke HJ; Hsieh CK; Kuo CW; Wang SY; Huang BW; Tseng JG; Wang FS Cell Death Dis; 2019 Sep; 10(10):705. PubMed ID: 31543513 [TBL] [Abstract][Full Text] [Related]
10. Critical role of beta3 integrin in experimental postmenopausal osteoporosis. Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265 [TBL] [Abstract][Full Text] [Related]
11. Identification of circRNA-associated ceRNA network in BMSCs of OVX models for postmenopausal osteoporosis. Wang H; Zhou K; Xiao F; Huang Z; Xu J; Chen G; Liu Y; Gu H Sci Rep; 2020 Jul; 10(1):10896. PubMed ID: 32616775 [TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitor RepSox prevented ovariectomy-induced osteoporosis by suppressing osteoclast differentiation and bone resorption. Mei L; Sang W; Chen Z; Zheng L; Jin K; Lou C; Huang W; He D J Cell Physiol; 2018 Dec; 233(12):9724-9738. PubMed ID: 30059597 [TBL] [Abstract][Full Text] [Related]
14. Effects of interleukin-7/interleukin-7 receptor on RANKL-mediated osteoclast differentiation and ovariectomy-induced bone loss by regulating c-Fos/c-Jun pathway. Zhao JJ; Wu ZF; Yu YH; Wang L; Cheng L J Cell Physiol; 2018 Sep; 233(9):7182-7194. PubMed ID: 29663382 [TBL] [Abstract][Full Text] [Related]
15. miR-346-3p promotes osteoclastogenesis via inhibiting TRAF3 gene. Mao Y; Chen Y; Fu Y; Guan J; Liang M; Zhu Y; Yang F; Li F; Zhang Z; Wan C; Zhou P In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):533-542. PubMed ID: 32839904 [TBL] [Abstract][Full Text] [Related]
16. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice. Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516 [TBL] [Abstract][Full Text] [Related]
17. miR-31 controls osteoclast formation and bone resorption by targeting RhoA. Mizoguchi F; Murakami Y; Saito T; Miyasaka N; Kohsaka H Arthritis Res Ther; 2013; 15(5):R102. PubMed ID: 24004633 [TBL] [Abstract][Full Text] [Related]
18. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [TBL] [Abstract][Full Text] [Related]
19. The miR-1906 mimic attenuates bone loss in osteoporosis by down-regulating the TLR4/MyD88/NF-κB pathway. Xie H; Cao L; Ye L; Shan G; Song W Physiol Int; 2021 Nov; 107(4):469-478. PubMed ID: 33410769 [TBL] [Abstract][Full Text] [Related]
20. Osteoclast-derived exosomes influence osteoblast differentiation in osteoporosis progression via the lncRNA AW011738/ miR-24-2-5p/ TREM1 axis. Liu J; Wang B; Chen H; Yu X; Cao X; Zhang H Biomed Pharmacother; 2024 Sep; 178():117231. PubMed ID: 39094542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]